Efficacy, safety, and immunogenicity of UB-851 versus ® in patients with renal anemia receiving hemodialysis: A randomized, double-masked, phase III trial
UB-851 与® 在接受血液透析的肾性贫血患者中的疗效、安全性和免疫原性：一项随机、双盲、III 期试验
期刊:
影响因子:
doi:10.1097/JCMA.0000000000001327
Wu, Chien-Hsing; Shiao, Chih-Chung; Wang, Hsien-Yi; Tian, Ya-Chung; Chiu, Yi-Wen; Huang, Wen-Hung; Tsai, Shin-Hung; Fang, Hua-Chang; Lee, Chin-Chan; Hsu, Bang-Gee; Chang, Horng-Rong; Lin, Chien-Yu; Chan, Chee-Hong; Wang, Wei-Jie; Huang, Kuo-Ching; Chen, Szu-Chia; Wang, Chia-Liang; Huang, Chung-Yu; Tarng, Der-Cherng
